November 2006 Volume 2, Issue 11
Volume 2, Issue 11 | November 2006
November 2006
In this Issue
Informatics
3-D map of mouse brain gene expression
The brain atlas details more than 21,000 genes at the cellular level.Bundled biomarker deal
InforSense, Thermo OEM agreement may accelerate protein biomarker discovery.Scientists link gene behavior with disease and drugs
Connectivity Map opens doors to early prediction of effective or detrimental drug candidates.BioIT Alliance targets biomarkers
BioIT Alliance begins the Biomarker Project and recruits Agilent.Genomics & Proteomics
Amgen acquires Avidia for $290 million
Deal sees biotech giant pick up Avimer proteins platform.Enzyme market penetration
Millipore’s global reach will help get JPT’s enzyme line worldwide customersCogenics, Algynomics team up on pain panel
Genetic markers to allow clients to examine the genetic basis or underpinnings of human pain.Automation & Instrumentation
NimbleGen signs license deal with Affymetrix
NimbleGen looking to diversify from its current service model.Beckman Acquires Lumigen
Chemiluminescent chemistries to be used in Beckman Coulter’s Access immunoassay systems.Is it easy being green?
CEM, EPA collaborate on chemistry scale-upResearch & Development
Cardiovascular collaboration
Servier taps Plexxikon for non-peptidic rennin inhibitor projectTag-teaming tuberculosis
Cumbre and TB Alliance announce partnership to develop new TB agentsRx3 recieves two NIH grants
Company wants to fight drug-resistant organisms.Yale, NFCR launch cancer drug research center
Five-year, $750,000 grant to develop new beta-peptide inhibitors.NGI co-develops R&D office, incubator with U. Iowa
Plans to build a new 80,000-sq.ft research center and business incubator.Global News
Microarrays have big future in store
SNP market at about $400 million; in next 5 years to $1 billion.Gilead Sciences to acquire Myogen for $2.5 billion
Myogen will become a wholly-owned subsidiary of Gilead.Neurotech organization to advance brain, nervous system therapies
Companies form a new trade association called the Neurotechnology Industry Organization (NIO).Teva, Protalix collaborate on two biopharmaceuticals
Companies to develop two proteins using Protalix’s plant cell culture platform.Editor's Focus
Metabolomics: Clearing the logjam for biomarkers
Although many analytical chemists and biochemists will claim they have been practicing the science of identifying small molecules in biological matrices long before 2000, most agree that as a robust discovery tool, the technology is new and rapidly evolving. Since then, there has been an explosion of papers describing the technology as well as a significant number of papers using the technology for the discovery of biomarkers.News Briefs
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
The unsung tools behind analytical testing success
Learn how fundamental laboratory tools like pipettes and balances support analytical precision.
Improving ALS research with pluripotent stem cell-derived models
Discover new advancements in modeling amyotrophic lateral sclerosis.
Automating 3D cell selection
Discover precise automated tools for organoid and spheroid handling.
